Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-14-050193

← back to feed
Filed
Aug 14, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 14, 2014 20.37M sh
Capex Q2 2014 · Jun 30, 2014 $120.27K
Capex Q2 2014 · Jun 30, 2013 $0
Stockholders Equity Q2 2014 · Jun 30, 2014 −$7.42M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$12.88M
Stockholders Equity Q2 2014 · Dec 31, 2012 −$12.27M
Stockholders Equity Q2 2014 · Jul 31, 2005 $0
Current Liabilities Q2 2014 · Jun 30, 2014 $2.48M
Current Liabilities Q2 2014 · Dec 31, 2013 $3.9M
Total Liabilities Q2 2014 · Jun 30, 2014 $23.36M
Total Liabilities Q2 2014 · Dec 31, 2013 $39.77M
Current Assets Q2 2014 · Jun 30, 2014 $15.91M
Current Assets Q2 2014 · Dec 31, 2013 $26.86M
Total Assets Q2 2014 · Jun 30, 2014 $15.95M
Total Assets Q2 2014 · Dec 31, 2013 $26.88M
Sga Expense Q2 2014 · Jun 30, 2014 $16.22M
Sga Expense Q2 2014 · Jun 30, 2013 $668.01K
Sga Expense Q2 2014 · Jun 30, 2013 $1.52M
Rd Expense Q2 2014 · Jun 30, 2014 $58.84M
Rd Expense Q2 2014 · Jun 30, 2013 $2.74M
Rd Expense Q2 2014 · Jun 30, 2013 $5.73M
Net Income Q2 2014 · Jun 30, 2014 −$86.51M
Net Income Q2 2014 · Dec 31, 2013 −$39.66M
Net Income Q2 2014 · Jun 30, 2013 −$11.3M
Net Income Q2 2014 · Jun 30, 2013 −$12.24M
Net Income Q2 2014 · Dec 31, 2012 −$14.39M
Net Income Q2 2014 · Dec 31, 2010 −$27.6M
Operating Income Q2 2014 · Jun 30, 2014 −$75.06M
Operating Income Q2 2014 · Jun 30, 2013 −$3.41M
Operating Income Q2 2014 · Jun 30, 2013 −$7.25M
Shares Diluted Q2 2014 · Jun 30, 2013 4.81M sh
Shares Diluted Q2 2014 · Jun 30, 2013 4.68M sh
Cash And Equivalents Q2 2014 · Jun 30, 2013 $4.55M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $10.94M
Cash And Equivalents Q2 2014 · Jul 31, 2005 $0
Eps Diluted Q2 2014 · Jun 30, 2013 −$2.35
Eps Diluted Q2 2014 · Jun 30, 2013 −$2.61
Eps Basic Q2 2014 · Jun 30, 2013 −$2.35
Eps Basic Q2 2014 · Jun 30, 2013 −$2.61